BOULDER, Colo., Dec. 8, 2022 /PRNewswire/ — The International Market Access Society (IMAS) is pleased to announce Dr Scott Gottlieb, Physician, Former FDA Commissioner, and Former CMS Senior Advisor, as the opening keynote speaker on April 4, 2023, for the ACCESS 2023 Annual Meeting & Expo in Miami Beach.
Dr Gottlieb will deliver an in-person keynote address on Healthcare Innovation and Affordability – Are They Compatible? He is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.
Over 400 market access professionals and stakeholders are expected to attend ACCESS 2023 at the Fontainebleau Miami Beach on April 3-5, the leading event in the US for leaders and stakeholders to shape the future of market access, pricing, and reimbursement.
Sessions will cover 5 major topic areas, over 2 days of plenary sessions, interactive workshops, engaging debate panels and oral presentations, including:
Optimal Market Access: Role of Real-World Evidence
Payer Strategies and the Changing Impact of Legislative Policies on Market Access
Patient Perspective and Role in Policy Decision Making – Imaginary or Real Influence?
Access Evolution in Low- and Middle-income Countries
The Latest and Most Important Access Methodologies, Frameworks, and Trends
For the latest agenda and confirmed speakers for ACCESS 2023, visit www.marketaccess.org/access2023. Super early bird rates are now in effect, with registration starting as low as $600.
Newt’s guest is David Trulio, President and CEO of the Ronald Reagan Presidential Foundation and Institute. They discuss the 35th anniversary of the fall of…
Tomorrow the House Ethic Committee is expected to discuss the fate of its report on Matt Gaetz, President-elect Trump’s choice for attorney general. The former Florida…